Rottendorf Pharma is one of the leading contract developers and manufacturers (CDMO) in the field of oral solid dosage forms and has been active in manufacturing and packaging as well as formulation and analytical process development for the international pharmaceutical industry for more than 95 years. Clients choose Rottendorf Pharma for its broad-ranging expertise, global regulatory capabilities, commitment to quality, state-of-the-art facilities, and exceptional customer service exemplified by Total Process Ownership and Total Technological Mastering. The company has more than 1,300 experienced and competent employees, including many formulation scientists and technicians. The production facilities meet the requirements of GMP, FDA, EMA, ANVISA and other national authorities.